The extracellular heat shock protein 90 (Hsp90) is known to participate in cell migration and invasion. Recently, we have shown that cell surface heparan sulfate proteoglycans (HSPGs) are involved in the binding and anchoring of extracellular Hsp90 to the plasma membrane, but the biological relevance of this finding was unclear. Here, we demonstrated that the digestion of heparan sulfate (HS) moieties of HSPGs with a heparinase I/III blend and the metabolic inhibition of the sulfation of HS chains by sodium chlorate considerably impair the migration and invasion of human glioblastoma A-172 and fibrosarcoma HT1080 cells stimulated by extracellular native Hsp90. Heparin, a polysaccharide closely related to HS, also reduced the Hsp90-stimulated migration and invasion of cells. Phorbol 12-myristate 13-acetate, an intracellular inducer of cell motility bypassing the ligand activation of receptors, restored the basal migration of heparinase-and chlorate-treated cells almost to the control level, suggesting that the cell motility machinery was insignificantly affected in cells with degraded and undersulfated HS chains. On the other hand, the downstream phosphorylation of AKT in response to extracellular Hsp90 was substantially impaired in heparinase-and chloratetreated cells as compared to untreated cells. Taken together, our results demonstrated for the first time that cell surface HSPGs play an important role in the migration and invasion of cancer cells stimulated by extracellular Hsp90 and that plasma membraneassociated HSPGs are required for the efficient transmission of signal from extracellular Hsp90 into the cell.
Introduction
The heat shock protein 90 (Hsp90) is one of the most abundant and ubiquitously expressed proteins that constitutes approximately 1-2% of the total cell protein content (Li and Buchner 2013) . There are two major cytoplasmic isoforms of Hsp90, Hsp90α (the inducible form) and Hsp90β (the constitutive form), that share a high-sequence homology but show differences in biochemical properties, expression, and function (Li and Buchner 2013; Sreedhar et al. 2004 ). Hsp90 acts inside cells as a chaperone that regulates the folding, maturation, transport, and degradation of a diverse set of client proteins, in particular, signaling molecules, steroid receptors, and transcription factors (Li and Buchner 2013; Sreedhar et al. 2004 ). The protein is localized not only inside the cell but also in the extracellular space (extracellular soluble Hsp90) and at the cell plasma membrane (extracellular membrane-associated Hsp90). Hsp90 is secreted by many types of cancer cells (Becker et al. 2004; Chen et al. 2010; Cheng et al. 2008; Li et al. 2007; McCready et al. 2010; Suzuki and Kulkarni 2010; Wang et al. 2009 ) and is found on the surface of numerous cells (Cheng et al. 2008; Crowe et al. 2017; Sidera et al. 2008) . Cell stressors such as oxidative stress, heat shock, and hypoxia, as well as growth factors, stimulate the translocation of Hsp90 to the plasma membrane and/or its secretion (Cheng et al. 2008; Clayton et al. 2005; Crowe et al. 2017; Gopal et al. 2011; Li et al. 2007; Song et al. 2010; Wang et al. 2009 ). The level of cell surface expression and secretion of Hsp90 in tumor cells is elevated, which correlates with the metastatic potential of cells (Becker et al. 2004; Hance et al. 2012) . Cell Electronic supplementary material The online version of this article (https://doi.org/10.1007/s12192-018-0955-5) contains supplementary material, which is available to authorized users.
surface Hsp90 is actively internalized by cancer cells (Crowe et al. 2017) . Extracellular Hsp90 promotes cell migration (Becker et al. 2004; Cheng et al. 2011; Gopal et al. 2011; Li et al. 2007; McCready et al. 2010; Sidera et al. 2004; Sidera et al. 2008 ) and skin wound healing (Cheng et al. 2011; Li et al. 2007 ) and stimulates the invasion and metastatic activities of cancer cells (Becker et al. 2004; Gopal et al. 2011; McCready et al. 2010; Sidera et al. 2008 ). There are several mechanisms of action of extracellular Hsp90 in cell motility. Hsp90 can function as a pro-motility factor by binding to a growing number of transmembrane cell surface receptors and inducing the signaling in normal and cancer cells (Basu et al. 2001; Chen et al. 2010; Cheng et al. 2008; El Hamidieh et al. 2012; Lei et al. 2004; Sidera et al. 2008) . Extracellular Hsp90 cooperates with the low-density lipoprotein-related protein (LRP1), activating various signaling pathways (Basu et al. 2001; Chen et al. 2010 Chen et al. , 2013 Cheng et al. 2008) . Hsp90 also binds to HER2, inducing EGFR3/HER2 dimerization and EGFR signaling (Sidera et al. 2008) . Extracellular Hsp90 participates in the ligand-independent EphA2 activation (Gopal et al. 2011 ) and TLR4-mediated activation of EGFR (Thuringer et al. 2011) . The protein also regulates the signaling of integrin by modulating its expression and interaction with Src to form focal adhesions (Chen et al. 2010; Tsutsumi et al. 2008) . Besides functioning as a pro-motility ligand that interacts with different cell surface receptors, extracellular Hsp90 can also increase the stability and activity of some surface-bound or secreted proteins, such as matrix metalloproteinases and extracellular matrix proteins, thus promoting cell motility and invasion (Correia et al. 2013; Hunter et al. 2014; Lagarrigue et al. 2010) .
Heparan sulfate proteoglycans (HSPGs) are abundant cellsurface and extracellular matrix glycoproteins that comprise a core protein to which heparan sulfate (HS) glycosaminoglycan chains are covalently attached (Gallagher 2015; Sarrazin et al. 2011) . On the surface of most mammalian cells, the representatives of two major families of HSPGs, glypicans and syndecans, are localized (Gallagher 2015; Sarrazin et al. 2011) . HSPGs are involved in many biological processes, including cell growth and division, development, embryogenesis, cell adhesion and motility, and cell signaling (Gallagher 2015; Mitsou et al. 2017; Sarrazin et al. 2011 ). Due to the structural diversity, the HS moieties of cell surface HSPGs are able to interact with a wide range of growth factors, morphogenic proteins, and cytokines, functioning as Blow-affinity^co-receptors to provide more efficient ligand interaction with Bhigheraffinity^receptors and signal transduction (Gallagher 2015; Lindahl and Li 2009; Sarrazin et al. 2011) . Recently, we have shown that extracellular Hsp90 interacts with the HS moieties of cell surface HSPGs (Snigireva et al. 2015) . The involvement of HSPGs in the biological activity of extracellular Hsp90 remains uncertain and warrants further investigation. Here, we demonstrated for the first time that cell surface HSPGs potentiate the Hsp90-generated signaling in human glioblastoma A-172 and fibrosarcoma HT1080 cells and thereby participate in the Hsp90-stimulated cell migration and invasion.
Materials and methods

Cell culture and reagents
Human glioblastoma A-172 and fibrosarcoma HT1080 cells were from the Cell Culture Collection of Vertebrates (St. Petersburg, Russia). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (DMEM-FBS) and antibiotics in a humidified atmosphere containing 5% CO 2 . FBS and DMEM were purchased from GE Healthcare. Transwell inserts with a polycarbonate membrane (8 μm) were from Corning. Basement membrane collagen IV was from Trevigen Inc. Polyvinylidene difluoride membrane was from Merck-Millipore. Rabbit phospho-AKT1/2/3 (Ser 473) antibodies (sc-4985-R) were purchased from Santa Cruz Biotechnology. Mouse monoclonal antibodies specific for Hsp90α (ab59459) and Hsp90β (ab53497) were from Abcam, heparin/HS (MAB2040) was from Merck-Millipore, LRP1 (MCA1965) was from Bio-Rad, and β-actin (sc-47,778) was from Santa Cruz Biotechnology. Secondary HRP-conjugated antibodies were from Bio-Rad. Alexa 488-labeled secondary conjugates were purchased from Jacksons ImmunoResearch Laboratories. Cell culture plastic labware was from Corning. All other chemicals were obtained from Sigma-Aldrich.
Purification of native Hsp90
Native mouse, swine, and bovine Hsp90s were purified from mouse, swine, and bovine brains as described earlier (Skarga et al. 2009 ). The cytotoxicity and аntiproliferative аctivity of native Hsp90 were determined using the MTT assay as described (Lisov et al. 2015) .
Wound-healing assay
In the experiments on enzymatic degradation of HS moieties, cells were grown in 35-mm culture dishes for 24 h at 37°C to form a Bfresh^confluent monolayer and then incubated for 1-2 h at 37°C with a heparinase I/III blend from Flavobacterium heparinum (Sigma-Aldrich) diluted in DMEM-FBS (0.03 IU/ ml). To inhibit the sulfation of HS chains, the cells were grown in 35-mm culture dishes in DMEM-FBS supplemented with 30 mM sodium chlorate for 24 h at 37°C to form a Bfreshĉ onfluent monolayer. A Bscratch^was created by scraping the monolayer of heparinase-and chlorate-treated cells in a straight line with a pipet tip. The cells were washed with DMEM and cultured in DMEM containing 0.2% BSA (DMEM-BSA) for 6 h at 37°C (basal migration) or in the presence of native Hsp90 (50 μg/ml) (Hsp90-stimulated migration). In each experiment, monolayers of control untreated cells were also wounded, and cells were stimulated by native Hsp90 in the same way. Pictures were taken immediately after cell wounding (0 h) and 6 h after cell wounding. The images were captured by a CCD camera (DM 2500, Leica), and wound areas were calculated using the Leica Application Suite v3.0. software. The basal migration of heparinase/ chlorate-treated cells was determined by comparing the wound areas of control and heparinase/chlorate-treated cells and expressed in percent (wound area of control untreated cells was taken as 100%). To calculate the degree of stimulation of cell migration/invasion by extracellular Hsp90, the wound area of Hsp90-stimulated cells was subtracted from that of unstimulated cells (basal migration), and the residual value was expressed in percent relative to the wound area of unstimulated cells (basal migration). Thus, the Hsp90-stimulated migration of control, heparinase-, and chloratetreated cells was calculated relative to the respective basal migration of control, heparinase-, and chlorate-treated cells.
To compare the Hsp90-stimulated migration of control and heparinase/chlorate-treated cells, the stimulation of migration of control cells was taken as 100%. To analyze the effect of heparin, chondroitin sulfate A, or dermatan sulfate on the basal and Hsp90-stimulated cell migration, the wound-healing assay was performed in the presence of sulfated glycosaminoglycans (50 μg/ml). To determine whether cells with degraded/undersulfated HS chains retain the capacity to migrate after appropriate stimulation, heparinase-and chloratetreated cells were induced with PMA diluted to a concentration of 100 nM in DMEM containing 2% FBS, and the migration of cells was determined in the wound-healing assay.
Transwell migration/invasion assays
In the experiments on enzymatic degradation of HS moieties, cells were grown in 35-mm culture dishes for 18 h to reach 80-90% confluence. Then cells were serum starved by incubation in DMEM-BSA for 24 h at 37°C, detached from culture dishes by incubation for 5 min at 37°C with 0.05% Na-EDTA, suspended in DMEM-BSA, and treated for 1-2 h at 37°C with a heparinase I/III blend (0.03 IU/ml). In the experiments on undersulfation of HS chains, cells were incubated at 37°C for 24 h in DMEM-FBS supplemented with 30 mM sodium chlorate and for 24 h in DMEM-BSA containing 30 mM sodium chlorate, followed by the detachment of cells from culture dishes as described above. The suspensions of heparinaseand chlorate-treated cells were washed with DMEM, suspended in DMEM-BSA in the presence and absence of native Hsp90 (50 μg/ml) to stimulate cell migration/invasion, and plated into the top chambers of transwell inserts. In the transwell migration assay, cells were allowed to migrate through a membrane for 6 h toward DMEM supplemented with 5% FBS in the bottom chambers to form a chemotactic gradient. In the transwell invasion assay, polycarbonate membranes of inserts were preliminarily coated with collagen IV (400 μg/ml) according to the manufacturer's recommendations, and cells migrated for 24 h toward the chemotactic gradient. Optimal migration times in the transwell migration and invasion assays were determined in preliminary experiments. After incubation, non-migrating cells on the upper side of the membrane were removed with a cotton swab, and invading cells attached to the bottom membrane were fixed with methanol, stained with crystal violet, and lysed with 10% acetic acid, after which the optical density was measured using a plate reader (iMax, Bio-Rad) at 495 nm (OD 495 To analyze the effect of heparin, chondroitin sulfate A, or dermatan sulfate on the basal and Hsp90-stimulated cell migration/invasion, the transwell migration/invasion assays were performed as described above in the presence of sulfated glycosaminoglycans (50 μg/ml).
Flow cytometry
Cells were treated with a heparinase I/III blend and sodium chlorate as described above. The influence of different sulfated glycosaminoglycans on the attachment of Hsp90α and Hsp90β to the plasma membrane was analyzed by treating the cells for 1 h at 37°C with heparin, chondroitin sulfate A, or dermatan sulfate diluted in DMEM-FBS to a concentration of 50 μg/ml. After the treatment, cells were detached from culture dishes by incubation for 5 min at 37°C with 0.05% Na-EDTA and washed with cold PBS containing 0.05% NaN 3 (PBS-NaN 3 ). The cells were incubated with primary mouse antibodies, washed, and incubated with Alexa 488-labeled anti-mouse IgG conjugates. All incubations with antibodies and conjugates were performed for 1 h at 4°C in PBS-NaN 3 containing 2% BSA. Then, cells were washed, fixed with 0.5% formaldehyde for 15 min at 4°C, and analyzed using an Accuri C6 flow cytometer (Becton Dickinson).
Autofluorescence and isotype controls were run routinely for all assays. Each analysis included at least 50,000 events of gated cells. The mean fluorescence intensity (MFI) was determined using the BD Accuri C6 software. To quantify the flow cytometry data, MFI of respective isotype controls were subtracted from specific MFI and the levels of surface proteins were expressed as the respective MFI ± SD.
Western blot analysis
Cells were treated with heparinase and sodium chlorate and stimulated by native Hsp90 as indicated above. Then, cells were lysed in PBS containing 1% Nonidet P-40, 0.5% deoxycholate, 0.3% SDS, 1 mM phenylmethylsulfonyl fluoride, 200 nM aprotinin, 50 μM leupeptin, 10 μM pepstatin A, and phosphatase inhibitor cocktail 3 (Sigma-Aldrich). Cell samples were separated by 10% SDS-PAGE and transferred onto a polyvinylidene difluoride membrane. The membrane was blocked in PBS containing 0.05% Tween 20 and 2% BSA (PBS-T-BSA), and membrane strips were probed with AKT1/2/3-, pAKT1/2/3-, or β-actin-specific antibodies. The strips were washed and incubated with HRP-conjugated secondary anti-rabbit IgG or anti-mouse IgG antibodies in PBS-T-BSA for 1 h. After thorough washing, immunoreactive bands were detected using the 3,3′-diaminobenzidine substrate. For the quantification, a densitometric analysis of Western blots was performed, following which band densities were normalized to β-actin (loading control) and quantified.
In preliminary experiments, the dynamic linear range of band intensities for quantitative estimations was determined. To analyze purified Hsp90s, Hsp90 preparations were separated by 10% SDS-PAGE, transferred onto a polyvinylidene difluoride membrane, and membrane strips were probed with Hsp90α-and Hsp90β-specific antibodies.
Statistical data analysis
The data represent the average of three and more independent experiments. The results are expressed as the mean ± SD. The statistical significance was determined by the Student's t test, and p < 0.05 was considered to be significant.
Results
Enzymatic degradation of HS moieties of cell surface HSPGs diminishes the Hsp90-stimulated migration and invasion of cells
We used native Hsp90s to stimulate the migration and invasion of human glioblastoma A-172 and fibrosarcoma HT1080 cells. Native Hsp90s were purified from mouse, swine, and bovine brains as described (Skarga et al. 2009 S2a ). Throughout the study, we used the purified native mouse Hsp90 at a concentration of 50 μg/ml. Mouse Hsp90 was not toxic for cells and did not affect the growth characteristics of A-172 and HT1080 cells at concentrations up to 1.0 mg/ml (additional file: Fig. S2b ), indicating that Hsp90 did not influence cell proliferation.
To elucidate the functional role of cell surface HSPGs in the Hsp90-stimulated migration/invasion of cells, HS moieties of HSPGs of HT1080 and A-172 cells were digested with heparinase followed by the analysis of the migration and invasion of cells in the presence of extracellular Hsp90. To ensure extensive degradation of the HS chains of HSPGs, a heparinase I/III blend was used since heparinase I and heparinase III specifically cleave, respectively, highly sulfated and less sulfated polysaccharide chains (Ernst et al. 1995) . After the treatment, the reactivity of cells with the heparin/HSspecific antibody strongly diminished, which confirmed the profound degradation of HS moieties of surface HSPGs (Fig. 1a) . The enzymatic degradation of cell surface HSPGs with heparinase was also accompanied by a considerable loss of Hsp90 isoforms from the cell surface (Fig. 1a) , which was consistent with the results of our previous study (Snigireva et al. 2015) . Further incubation of heparinase-treated cells in DMEM-FBS at 37°C led to the coordinated restoration of the levels of Hsp90α, Hsp90β, and HSPGs at the cell surface; the almost complete restoration of cell surface expression of Hsp90s and HSPGs occurred within 6 h. The amount of cell surface LRP1 did not change during the treatment of cells with heparinase (Fig. 1a) .
The enzymatic digestion of HSPGs also led to a 25-60% decrease in the basal (unstimulated) migration of cells in both migration assays and to a 25-50% reduction in the basal invasion of cells (Fig. 1b, c) as compared to control untreated cells. Moreover, extracellular Hsp90 less efficiently stimulated the migration/invasion in cells with heparinase-degraded HS moieties, as compared to control cells. Namely, after the digestion of HS moieties, the stimulation of cell migration by native Hsp90 in the wound-healing and transwell assays decreased by 50-65% as compared to the stimulation of control cells treated with Hsp90 in the same conditions (Fig. 1b, d ). In the transwell invasion assay, the stimulation of invasion of heparinase-treated A-172 and HT1080 cells was reduced less significantly, by 10-30%, as compared to the stimulation of control cells (Fig. 1d) . The results indicated that cell surface HSPGs are involved both in the basal and Hsp90-stimulated migration and invasion of cancer cells in vitro. Though the treatment of cells with heparinase drastically reduced the quantity of HS moieties on the surface, the cells were still able to respond to the treatment with extracellular Hsp90. Thus, extracellular Hsp90 is able to activate to some extent cell motility in an HSPG-independent manner, and surface HSPGs promote the Hsp90-induced stimulation of cell migration and invasion.
Undersulfation of HS moieties of HSPGs decreases the Hsp90-stimulated migration and invasion of cells
We further examined the effect of inhibition of sulfation of HS chains on the Hsp90-stimulated migration/invasion of cells. Sodium chlorate reduces the sulfation of HSPG polysaccharide chains during their biosynthesis (Safaiyan et al. 1999) . We observed that the cultivation of cells in a medium containing sodium chlorate at a concentration of 30 mM for 24-48 h did not affect cell proliferation and viability (data not shown). The treatment of cells for 24 h with sodium chlorate led to a 5-20-fold diminishing in the reactivity of the HS-specific antibody with cells, indicating a dramatic decrease in the quantity of sulfated HS moieties on the cell surface (Fig. 2a) . The undersulfation of HSPGs with sodium chlorate was also accompanied by a considerable decrease in the levels of Hsp90α and Hsp90β at the cell surface, whereas the level of cell surface LRP1 decreased only by 20-30% (Fig. 2a) . Further incubation of chlorate-treated cells in DMEM-FBS without chlorate at 37°C resulted in a restoration of the levels of HSPGs and both Hsp90 isoforms at the cell surface that lasted for more than 24 h (Fig. 2a) . The dynamics of the restoration of Hsp90α and Hsp90β levels at the cell surface correlated with that of HSPGs.
Chlorate-treated cells migrated slower by 65-85% and 40-45% in the wound-healing and transwell migration assays, respectively, as compared to untreated cells (Fig. 2b, c) . The basal invasion of chlorate-treated cells was also reduced, approximately by 50% (Fig. 2c) . In addition to reduced basal migration and invasion, cells with undersulfated HSPGs exhibited a decrease in the stimulation of migration/invasion by extracellular Hsp90. Namely, the Hsp90-induced stimulation of migration of chlorate-treated cells decreased by 50-80% in the wound-healing assay and transwell migration assay as compared to that of control cells stimulated by Hsp90 (Fig.  2b, d ). The Hsp90-stimulated invasion of chlorate-treated cells relative to control cells decreased by 10-20% (Fig. 2d) . Altogether, the results further support our conclusion that cell surface HSPGs are involved in the basal and Hsp90-stimulated migration and invasion of cancer cells. Similarly to the enzymatic degradation of HSPGs, the metabolic inhibition of the sulfation of HS chains did not completely abrogate the stimulation of cells with extracellular Hsp90, suggesting that cell surface HSPGs rather facilitate the Hsp90-induced stimulation of cell migration/invasion than are absolutely required for this.
Heparin decreases the Hsp90-stimulated migration and invasion of cells
To further assess the involvement of cell surface HSPGs in the Hsp90-stimulated cell motility, we analyzed the effects of different sulfated glycosaminoglycans on the Hsp90-stimulated migration/invasion of A-172 and HT1080 cells. Heparin, a polysaccharide closely related to HS (Sarrazin et al. 2011) , at a concentration of 50 μg/ml decreased the levels of Hsp90α and Hsp90β at the cell surface in both cancer cell lines by 30-55% and 60-80%, respectively (Fig. 3a) . On the Fig. 2 Metabolic inhibition of sulfation of HS chains leads to a loss of sulfated groups of HS, Hsp90α, and Hsp90β from the cell surface (a) and to an inhibition of the basal and Hsp90-stimulated cell migration and invasion (b-d). a Cells were treated with sodium chlorate, after which cells were grown at 37°C in DMEM-FBS without chlorate. At indicated times, cell surface HS and proteins were stained with specific antibodies, analyzed by flow cytometry, and quantified. The data are presented as the MFI specific for HS, Hsp90α, Hsp90β, and LRP1, expressed in percent. The specific MFI of control untreated cells was taken as 100%. b The migration of chlorate-treated cells in the wound-healing assay in the presence and absence of Hsp90. c The analysis of the basal migration/ invasion of chlorate-treated cells. The basal migration/invasion of cells expressed in percent is presented. The basal migration/invasion of untreated control cells was taken as 100%. d The Hsp90-stimulated migration and invasion of chlorate-treated cells. The Hsp90-stimulated migration/invasion was calculated as described in the BMaterials and methods^section and expressed in percent. The Hsp90-stimulated migration/invasion of control untreated cells was taken as 100%. a, c, d Each bar represents the mean ± SD (n = 3-4). *p < 0.05 and **p < 0.01 indicate statistically significant differences. The representative results from three independent experiments are shown A. V. Snigireva et al. contrary, two other cell surface glycosaminoglycans, chondroitin sulfate A and dermatan sulfate, either did not dissociate or slightly dissociated Hsp90s from the cell surface (Fig. 3a) . The results confirmed the specificity of the binding of Hsp90α and Hsp90β to the HS moieties of HSPGs, but not to cell surface proteoglycans containing chondroitin sulfate A and dermatan sulfate. The effect of heparin on the basal and Hsp90-stimulated migration and invasion was studied in the transwell migration and invasion assays.
Basal migration
In the presence of heparin in the medium (50 μg/ml), the basal migration of A-172 and HT1080 cells was reduced by 30-50%, and the basal invasion of cells was suppressed by 40-80% (Fig. 3b) . Heparin also decreased the degree of stimulation of cell migration by extracellular Hsp90: in the presence of heparin, the Hsp90-stimulated migration was reduced by 40-90% as compared to that without heparin (Fig. 3c) . In the invasion assay, heparin also lowered the Hsp90-stimulated invasion of cells by 60-95% (Fig. 3c) . In marked contrast, chondroitin sulfate A and dermatan sulfate did not change or only slightly decreased the Hsp90-stimulated cell migration. In the presence of chondroitin sulfate A and dermatan sulfate, the Hsp90-stimulated invasion of HT1080 cells diminished by 40-60% and 15-20%, respectively. In A-172 cells, chondroitin sulfate A and dermatan sulfate reduced the Hsp90-stimulated invasion by 15-30% (Fig. 3c) . The results provided further evidence for the participation of cell surface HSPGs in the Hsp90-stimulated cell motility. The stimulation of cells with extracellular Hsp90 was not completely inhibited by heparin, suggesting the ability of extracellular Hsp90 to stimulate cell migration/invasion in the absence of its binding to HSPGs.
Heparinase-and chlorate-treated cells can migrate given an appropriate stimulus
To test whether the negative effects of heparinase and sodium chlorate were specific to Hsp90-stimulated motility or to cell motility in general, independently of the nature of the stimulus, we investigated the influence of phorbol 12-myristate 13-acetate (PMA) on the migration of cells with enzymatically degraded and undersulfated HS moieties of HSPGs. PMA is known as a potent intracellular agonist of protein kinase C capable to bypasses the ligand activation of receptors and directly activate cell motility (Nomura et al. 2007 ). Heparinaseand chlorate-treated cells migrated in the wound-healing assay 35-65% slower as compared to untreated cells (Fig. 4) . PMA increased the rate of migration of control cells by 20-65%. In the presence of PMA, the rate of migration of heparinase-and chlorate-treated cells almost approached the rate of migration of PMA-induced control cells: the difference in the cell migration of PMA-induced control, heparinase-, and chlorate-treated cells was insignificant at a 95% confidence level (Fig. 4) . Thus, given an appropriate intracellular stimulus, the migration of heparinase-and chlorate-treated cells was comparable to that of control cells, indicating that the degradation/undersulfation of HS chains of cell surface HSPGs did not considerably affect the cell motility machinery.
Inhibition of the Hsp90-stimulated cell migration and invasion by the degradation/undersulfation of HS moieties of cell surface HSPGs occurs at the level of signal generation
Since the degradation and undersulfation of HS moieties did not affect the cell motility machinery, the decreased stimulation of migration and invasion of heparinase-and chloratetreated cells by extracellular Hsp90 may be related to the impairment of transmission of Hsp90-generated signal from the cell surface into cells with digested/undersulfated HS chains.
The stimulation of cells with extracellular Hsp90 leads to a receptor-mediated activation of different signaling pathways through phosphorylation of different kinases (Chen et al. 2010 Gopal et al. 2011; Thuringer et al. 2011) . The activation of AKT-mediated pathway appears essential (though not sufficient) for the Hsp90-induced motility response (Chen et al. 2010 Gopal et al. 2011; Thuringer et al. 2011) , and the level of phosphorylated AKT can be used to evaluate the efficiency of Hsp90 signaling in cells. Therefore, we monitored the phosphorylation status of AKT in heparinase-and chlorate-treated cells in response to extracellular Hsp90. The intensities of total AKT bands were virtually equal in different samples, indicating that the treatment of cells with heparinase and sodium chlorate and subsequent 2-h incubation of cells with Hsp90 did not change significantly the total AKT level in the cells. As expected, a 2-h treatment of A-172 and HT1080 cells with Hsp90 (50 μg/ml) raised the level of phosphorylated AKT in control untreated cells two to four times (Fig. 5) , which is consistent with the results obtained by other researchers (Chen et al. 2010 Gopal et al. 2011; Thuringer et al. 2011) . The stimulation of heparinaseand chlorate-treated cells with Hsp90 also led to an increase in the phosphorylation of AKT, but the increase was less pronounced: the level of phosphorylated AKT in heparinase-and chlorate-treated cells was reduced 1.3-2.8 and 2.0-2.5 times, respectively, as compared to control cells (Fig. 5) . In chloratetreated cells, the basal level of phosphorylated AKT was also slightly decreased. The degradation and undersulfation of HS did not completely abrogate but considerably inhibited the phosphorylation of AKT (Fig. 5) , suggesting that cell surface HSPGs are not absolutely required for the extracellular Hsp90-induced signaling. The results provided direct evidence for the important role of cell surface HSPGs in potentiating the Hsp90-induced signaling.
Discussion
Earlier we have shown that cell surface HSPGs are involved in the binding of extracellular Hsp90 to cells (Snigireva et al. 2015) . HSPGs can act at the cell surface as co-receptors for a range of structurally diverse effector proteins, and it seems likely that many of regulatory signals in the microenvironment of cells converge on HSPGs. HS chains interact with a wide range of growth factors, morphogenic proteins, and other soluble effectors (FGFs, HGF, VEGF, TGF-b1, TGF-b2, CC and presented. The basal migration/invasion of control cells without sulfated glycosaminoglycans was taken as 100%. c The Hsp90-stimulated migration/invasion of cells in the presence of heparin, chondroitin sulfate A, or dermatan sulfate at a concentration of 50 μg/ml was determined. The Hsp90-stimulated migration/invasion was calculated as described in the BMaterials and methods^section and expressed in percent. The Hsp90-stimulated migration/invasion of control cells without sulfated glycosaminoglycans was taken as 100%. a-c Each bar represents the mean ± SD (n = 3-5). *p < 0.05 and **p < 0.01 indicate statistically significant differences. The representative results from three independent experiments are shown CXC chemokines, and other soluble ligands), and play a role of Blow-affinity^cell surface co-receptors that operate in dualreceptor systems to facilitate ligand binding to other higheraffinity receptors that transduce signals into the cell (Gallagher 2015; Lindahl and Li 2009; Sarrazin et al. 2011) . Presumably, there are several distinct mechanisms by which cell surface HSPGs act as co-receptors. HSPGs may serve to sustain ligand gradients, deliver signaling proteins to signaling receptors, or directly participate in the formation of signaling complexes. HSPGs can also modulate ligand-receptor interactions by altering the stability or conformation of ligands. We hypothesized that the binding of HSPGs with extracellular Hsp90 may modulate its pro-motility activity. We used three approaches to investigate the role of cell surface HSPGs in the migration and invasion of human glioblastoma A-172 and fibrosarcoma HT1080 cells stimulated by extracellular Hsp90. The Hsp90-stimulated migration and invasion were investigated in cells treated with (1) a heparinase I/III blend, very specific enzymes for a mild elimination of HS from HSPGs (Ernst et al. 1995) ; (2) sodium chlorate, a specific metabolic inhibitor of glycosaminoglycan sulfation, that produces no observable effects on either protein synthesis or phosphorylation (Baeuerle and Huttner 1986; Safaiyan et al. 1999) ; and (3) heparin, a polysaccharide structurally similar to the HS moiety of HSPGs (Sarrazin et al. 2011) . All three treatments led to a decrease in cell migration and invasion stimulated by native extracellular Hsp90, indicating an important role of surface-associated HSPGs in the Hsp90-stimulated migration and invasion of cells. The treatment of cells with heparinase, sodium chlorate, and heparin also affected the basal migration/invasion of cells. When analyzing the Hsp90-stimulated cell migration and invasion in treated cells, we considered the decrease in the basal migration/invasion of cells. Therefore, the Hsp90-stimulated migration/invasion of cells was calculated as a percent of stimulation of migration/ invasion of control, heparinase-, chlorate-, and heparin-treated cells relative to the basal migration of, respectively, control, heparinase-, chlorate-, and heparin-treated cells. We suppose that the weaker effects of degradation/ undersulfation of HS moieties of HSPGs on the Hsp90-stimulated invasion than on the Hsp90-stimulated migration of cells can be explained by the different dynamics of the restoration of HS chains after different treatments. The HS level at the cell surface was almost fully restored within 6 h after the treatment of cells with heparinase and within more than 24 h after the treatment with sodium chlorate; the level of LRP1 decreased insignificantly during both treatments. Thus, in the course of the migration assay (6 h), the quantity of HS chains at the cell surface was reduced as compared to that in the invasion assay (24 h). We speculate that the more complete restoration of HS moieties of HSPGs in the invasion assay is advantageous for cell stimulation with extracellular Hsp90 and leads to an increase in the stimulation of heparinase/ chlorate-treated cells in the transwell invasion assay.
The treatment of cells with heparinase had a more pronounced inhibitory effect on the basal invasion than on the Hsp90-stimulated invasion. Probably, the basal invasion is more dependent on the integrity of the surface HS than the Hsp90-stimulated invasion. Also, we should take into account that extracellular Hsp90 is able to stimulate cell migration/ * * * * * * * Each bar represents the mean ± SD (n = 3-4). *p < 0.05 and **p < 0.01 indicate statistically significant differences. The representative results from three independent experiments are shown invasion in a HS-independent manner, which probably makes the Hsp90-mediated invasion less dependent on the surface HS.
The reduced stimulation of cell motility by extracellular Hsp90 in cells with digested/undersulfated HS chains can be explained either by the impairment of the motility machinery of the cell or by the inhibition of signal transduction from extracellular Hsp90 via cell receptors into the cell. We showed that the inhibition of Hsp90-driven stimulation of cell motility in heparinase-and chlorate-treated cells is brought about at the level of specific signal transduction through Hsp90 surface receptors. This was confirmed by the assay using PMA, an intracellular cell motility activator, that bypasses ligand activation of receptors (Nomura et al. 2007) , and also by the analysis of downstream signaling in response to extracellular Hsp90. Indeed, heparinase-and chlorate-treated cells remained responsive to PMA and, after being treated with PMA, restored the basal migration almost to the control level, which suggested that the cell motility machinery was insignificantly affected in cells with degraded/undersulfated HS. The results were in concordance with other results demonstrating the retention of migration activity of cells after elimination of HS moieties and alteration in their sulfation (Chiodelli et al. 2011; Deakin and Lyon 1999) . To evaluate the efficiency of Hsp90-induced cell signaling, we analyzed the level of phosphorylated AKT in cells with degraded/undersulfated HS chains since the AKT-mediated pathway, together with other signaling pathways, were reported to be activated in response to extracellular Hsp90 (Chen et al. 2010 Gopal et al. 2011; Thuringer et al. 2011) . We observed that the phosphorylation of AKT in heparinase-and chlorate-treated cells in response to stimulation with extracellular Hsp90 was substantially reduced, indicating the impairment of signaling from extracellular Hsp90 into the cell.
Mechanistically, our findings support the idea that the optimal pro-motility activity of extracellular Hsp90 is dependent upon the presence of cell surface HSPGs that bind Hsp90. At the same time, extracellular native Hsp90 is able to induce signaling and activate cell motility in an HSPG-independent manner. Profound enzymatic degradation of HS moieties of HSPGs, severe undersulfation of HS, and the treatment of 
